Posted by Michael Wonder on 08 May 2020
Health care leaders question how remdesivir is being distributed
8 May 2020 - Hospitals and doctors seek more transparency on what criteria the Trump administration is using to ship the drug.
Health-care leaders are expressing concern over how the Trump administration plans to distribute the promising coronavirus drug remdesivir, saying they are in the dark about the allocation criteria being used and are worried it isn’t based on need.
Some hospital officials say they have been informed they can’t get the drug since the federal government took over its allocation following the Food and Drug Administration’s emergency use authorisation on May 1.
